Related Experiment Video
Updated: Sep 26, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
[Stenting of the femoral artery: the angiologist's perspective]
1I. Medizinische Klinik, Schwerpunkt Angiologie, Klinikum der Johann Wolfgang Goethe-Universität, Theodor Stern Kai 7, 60590 Frankfurt am Main. bauersachs@em.uni-frankfurt.de
Insights
Percutaneous transluminal angioplasty is effective for femoral artery blockages. However, femoral artery stenting increases restenosis risk, limiting its use to specific cases and necessitating further research into hyperplasia inhibition.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Biomedical Engineering
Context:
- Percutaneous transluminal angioplasty (PTA) is a standard treatment for femoral artery stenosis and occlusions.
- Stent placement during PTA can lead to intimal hyperplasia and restenosis.
- Current guidelines recommend femoral artery stenting only in specific complex cases.
Purpose:
- To review the current indications and limitations of femoral artery stenting.
- To discuss the risks associated with stent placement, particularly restenosis and mechanical failure.
- To highlight the need for improved methods to prevent intimal hyperplasia.
Summary:
- Femoral artery angioplasty is safe and effective for treating blockages.
- Stenting increases the risk of restenosis due to intimal hyperplasia, making it suitable only for specific situations like dissections or severe stenosis.
- Stents near joints are discouraged due to potential structural damage.
Impact:
- Current recommendations for femoral artery stenting may change with the advent of new technologies.
- Future advancements like brachytherapy or drug-eluting stents (e.g., sirolimus-coated) could improve outcomes.
- Minimizing intimal hyperplasia is key to optimizing long-term results of endovascular interventions.
Abstract:
The percutaneous transluminal angioplasty of stenosis and short occlusions of the femoral artery is a well established, safe and effective treatment option. The additional placement of stents during angioplasty is associated with frequent and rapid restenosis due to intimal hyperplasia. Therefore, stent placement of the femoral artery is commonly recommended only for special circumstances, including PTA-induced dissection of the vessel wall, elastic recoil, and eccentric stenosis. Placement of stents near joints, e. g. in the common femoral artery or the popliteal artery should be avoided as it may lead to structural damage of the stents. The current angiological statement concerning stent implantation in the femoral artery may be revised if effective measures to inhibit intimal hyperplasia such as brachytherapy or sirolimus coated stents become available.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Imaging Studies VII: Vascular Imaging